宣泰医药：聘任吴一鸣、李方立担任公司副总经理

Core Points - JianSheng Wan, a non-independent director and core technical personnel, resigned due to age reasons and will no longer hold any position in the company [2] - Larry Yun Fang, the deputy general manager and core technical personnel, also resigned due to age reasons but will continue to hold other positions in the company and has been nominated as a non-independent director candidate [3] - MaoJian Gu, a non-independent director, will no longer participate in specific technical research but will continue in other roles and as a non-independent director [4] Management Changes - The company held its 16th meeting of the second board on April 30, 2025, where it approved the appointment of Wu Yi Ming and Li Fang Li as deputy general managers [4] - Wu Yi Ming was also appointed as the financial officer, while Wei Pei Hua will continue in the company but will no longer serve as the financial officer [4] - Shen Qiang and Zhou Hai Feng have been newly recognized as core technical personnel based on their qualifications and the company's future needs [4]